| Literature DB >> 31371577 |
Jasmin Herz1, Brian G Vassallo2, Stephan P Rosshart3, Ashli Hunter2, Morgan K Wall1, Jonathan H Badger4, John A McCulloch4, Dimitrios G Anastasakis5, Aishe A Sarshad5, Irina Leonardi6, Nicholas Collins7, Joshua A Blatter8, Seong-Ji Han7, Samira Tamoutounour7, Svetlana Potapova9, Mark B Foster St Claire9, Wuxing Yuan4,10, Shurjo K Sen4,10, Matthew S Dreier2, Benedikt Hild2, Markus Hafner5, David Wang11, Iliyan D Iliev6, Yasmine Belkaid7, Giorgio Trinchieri4, Barbara Rehermann3.
Abstract
Laboratory mouse studies are paramount for understanding basic biological phenomena but also have limitations. These include conflicting results caused by divergent microbiota and limited translational research value. To address both shortcomings, we transferred C57BL/6 embryos into wild mice, creating "wildlings." These mice have a natural microbiota and pathogens at all body sites and the tractable genetics of C57BL/6 mice. The bacterial microbiome, mycobiome, and virome of wildlings affect the immune landscape of multiple organs. Their gut microbiota outcompete laboratory microbiota and demonstrate resilience to environmental challenges. Wildlings, but not conventional laboratory mice, phenocopied human immune responses in two preclinical studies. A combined natural microbiota- and pathogen-based model may enhance the reproducibility of biomedical studies and increase the bench-to-bedside safety and success of immunological studies.Entities:
Mesh:
Year: 2019 PMID: 31371577 PMCID: PMC7377314 DOI: 10.1126/science.aaw4361
Source DB: PubMed Journal: Science ISSN: 0036-8075 Impact factor: 47.728